Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Antonini

Showing results (121-130 of 495) with videos related to

Pageof 50
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2023
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's DiseaseEleonora Fiorenzato, Sadaf Moaveninejad, Luca Weis, et al.
Journal of Parkinson'S Disease|June 19, 2023
Infusion Therapies in the Treatment of Parkinson's DiseaseTeus van Laar, K Ray Chaudhuri, Angelo Antonini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 20, 2017
ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's diseaseAngelo Antonini, Paolo Barone, Ubaldo Bonuccelli, et al.
Recenti Progressi in Medicina|December 19, 2003
[Cost analysis in Italy of various strategies for the treatment of Parkinson disease in the advanced phase]Anna D'Ausilio, Stefano Marconi, Angelo Antonini, et al.
The New England Journal of Medicine|January 5, 2007
Valvular heart disease and the use of dopamine agonists for Parkinson's diseaseRenzo Zanettini, Angelo Antonini, Gemma Gatto, et al.
Journal of Drug Assessment|November 9, 2019
Risk factors for impulse control disorders and related behaviors in Parkinson's disease: secondary analyses of the ICARUS studyPaolo Barone, Angelo Antonini, Paolo Stanzione, et al.
Movement Disorders Clinical Practice|May 18, 2022
Antiphospholipid-Related Chorea: Two Case Reports and Role of Metabolic ImagingLisa Lerjefors, Silvia Andretta, Giulia Bonato, et al.
Plos One|January 28, 2014
Grey matter changes in cognitively impaired Parkinson's disease patientsIrena Rektorova, Roberta Biundo, Radek Marecek, et al.
Movement Disorders Clinical Practice|January 12, 2024
How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's DiseaseDana Brinker, Katarzyna Smilowska, Steffen Paschen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 6, 2021
Dopamine Receptors in Parkinson's Disease: A Meta-Analysis of Imaging StudiesValtteri Kaasinen, Tero Vahlberg, A Jon Stoessl, et al.
Pageof 50

Showing results (121-130 of 495) with videos related to

Sort By:
Pageof 50
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2023
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's DiseaseEleonora Fiorenzato, Sadaf Moaveninejad, Luca Weis, et al.
Journal of Parkinson'S Disease|June 19, 2023
Infusion Therapies in the Treatment of Parkinson's DiseaseTeus van Laar, K Ray Chaudhuri, Angelo Antonini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 20, 2017
ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's diseaseAngelo Antonini, Paolo Barone, Ubaldo Bonuccelli, et al.
Recenti Progressi in Medicina|December 19, 2003
[Cost analysis in Italy of various strategies for the treatment of Parkinson disease in the advanced phase]Anna D'Ausilio, Stefano Marconi, Angelo Antonini, et al.
The New England Journal of Medicine|January 5, 2007
Valvular heart disease and the use of dopamine agonists for Parkinson's diseaseRenzo Zanettini, Angelo Antonini, Gemma Gatto, et al.
Journal of Drug Assessment|November 9, 2019
Risk factors for impulse control disorders and related behaviors in Parkinson's disease: secondary analyses of the ICARUS studyPaolo Barone, Angelo Antonini, Paolo Stanzione, et al.
Movement Disorders Clinical Practice|May 18, 2022
Antiphospholipid-Related Chorea: Two Case Reports and Role of Metabolic ImagingLisa Lerjefors, Silvia Andretta, Giulia Bonato, et al.
Plos One|January 28, 2014
Grey matter changes in cognitively impaired Parkinson's disease patientsIrena Rektorova, Roberta Biundo, Radek Marecek, et al.
Movement Disorders Clinical Practice|January 12, 2024
How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's DiseaseDana Brinker, Katarzyna Smilowska, Steffen Paschen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 6, 2021
Dopamine Receptors in Parkinson's Disease: A Meta-Analysis of Imaging StudiesValtteri Kaasinen, Tero Vahlberg, A Jon Stoessl, et al.
Pageof 50